Sprint Faces Difficulties and 3 Stock Analyses Not to Ignore
Sprint Nextel Corp. (NYSE:S): Stifel has stated that Sprint’s current difficult situation is ongoing due to a possible stronger competitor, a leveraged balance sheet, and challenging network integration.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Allergan Inc. (NYSE:AGN): According to Wells Fargo, the results from the Anticholinergic vs. Botox Comparison have been published in the study in the New England Journal of Medicine which should be a small positive for Allergan, since it will likely raise the awareness of the drug as a treatment option for overactive bladder. The firm keeps its Outperform rating on the stock.
Express-1 Expedited Solutions, Inc. (AMEX:XPO) shares have an Outperform rating and an $18 price target.
AT&T, Inc. (NYSE:T) and Verizon stock options are active into ex-dividend.